关注
Sergio Fernandez Bertolin
Sergio Fernandez Bertolin
Investigador en Institut Universitari d'investigació en Atenció Primària "Jordi Gol"
在 idiapjgol.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled …
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
MedRxiv, 2020
1752020
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
DR Morales, MM Conover, SC You, N Pratt, K Kostka, T Duarte-Salles, ...
The Lancet Digital Health 3 (2), e98-e114, 2021
1462021
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
The Lancet Rheumatology 2 (11), e698-e711, 2020
1272020
Patterns of multimorbidity in a population-based cohort of older people: sociodemographic, lifestyle, clinical, and functional differences
A Marengoni, A Roso-Llorach, DL Vetrano, S Fernández-Bertolín, ...
The Journals of Gerontology: Series A 75 (4), 798-805, 2020
942020
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahao, ...
Nature communications 11 (1), 5009, 2020
902020
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
E Burn, T Duarte-Salles, S Fernandez-Bertolin, C Reyes, K Kostka, ...
The Lancet Infectious Diseases 22 (8), 1142-1152, 2022
822022
The natural history of symptomatic COVID-19 during the first wave in Catalonia
E Burn, C Tebé, S Fernandez-Bertolin, M Aragon, M Recalde, E Roel, ...
Nature communications 12 (1), 777, 2021
762021
Thirty-day outcomes of children and adolescents with COVID-19: an international experience
T Duarte-Salles, D Vizcaya, A Pistillo, P Casajust, AG Sena, LYH Lai, ...
Pediatrics 148 (3), 2021
562021
Soft clustering using real-world data for the identification of multimorbidity patterns in an elderly population: cross-sectional study in a Mediterranean population
C Violán, Q Foguet-Boreu, S Fernández-Bertolín, M Guisado-Clavero, ...
BMJ open 9 (8), e029594, 2019
562019
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
EH Tan, AG Sena, A Prats-Uribe, SC You, WUR Ahmed, K Kostka, ...
Rheumatology 60 (SI), SI37-SI50, 2021
482021
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
RD Williams, AF Markus, C Yang, T Duarte-Salles, SL DuVall, T Falconer, ...
BMC Medical Research Methodology 22 (1), 35, 2022
472022
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient …
E Burn, X Li, K Kostka, HM Stewart, C Reich, S Seager, T Duarte‐Salles, ...
Pharmacoepidemiology and Drug Safety 31 (5), 495-510, 2022
442022
Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South …
T Duarte-Salles, D Vizcaya, A Pistillo, P Casajust, AG Sena, LYH Lai, ...
Medrxiv, 2020
372020
Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: a population‐based multistate cohort study including 4 618 377 adults in Catalonia, Spain
E Roel, A Pistillo, M Recalde, S Fernández‐Bertolín, M Aragon, ...
International Journal of Cancer 150 (5), 782-794, 2022
342022
Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study
N Villén, M Guisado-Clavero, S Fernández-Bertolín, A Troncoso-Mariño, ...
BMC geriatrics 20, 1-13, 2020
322020
Five-year trajectories of multimorbidity patterns in an elderly Mediterranean population using Hidden Markov Models
C Violán, S Fernández-Bertolín, M Guisado-Clavero, Q Foguet-Boreu, ...
Scientific reports 10 (1), 16879, 2020
322020
Body mass index and risk of COVID-19 diagnosis, hospitalization, and death: a cohort study of 2 524 926 catalans
M Recalde, A Pistillo, S Fernandez-Bertolin, E Roel, M Aragon, ...
The Journal of Clinical Endocrinology & Metabolism 106 (12), e5030-e5042, 2021
292021
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS
K Kostka, T Duarte-Salles, A Prats-Uribe, AG Sena, A Pistillo, S Khalid, ...
Clinical Epidemiology, 369-384, 2022
282022
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study
E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahão, ...
medRxiv, 2020.04. 22.20074336, 2020
282020
The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths …
E Burn, C Tebé, S Fernandez-Bertolin, M Aragon, M Recalde, E Roel, ...
MedRxiv, 2020.07. 13.20152454, 2020
262020
系统目前无法执行此操作,请稍后再试。
文章 1–20